Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers

Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers

Conflicting results have been reported regarding the prevalence of screen-detected human epidermal growth factor receptor 2 (HER2)-positive breast carcinomas and non-screen detected HER2-positive breast carcinomas. To address this issue, we evaluated the prevalence of HER2-positive breast carcinomas...

Full description

Bibliographic Details
Main Authors: M. Ángeles López-García, Irene Carretero-Barrio, Belén Pérez-Míes, Miguel Chiva, Carolina Castilla, Begoña Vieites, José Palacios
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
breast cancer
screening
HER2
estrogen receptor
progesterone receptor
triple negative
Online Access:https://www.mdpi.com/2072-6694/12/6/1578

Similar Items

Similar Items